Skip to main content

BioLineRx Ltd. (NASDAQ: BLRX) Investor Securities Class Action Lawsuit 01/05/2023

  • If you purchased a significant amount of shares of BioLineRx Ltd. (NASDAQ: BLRX) between February 23, 2021 and September 19, 2022, and / or if you purchased any NASDAQ: BLRX shares prior to February 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 6, 2023. NASDAQ: BLRX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 5, 2023 - An amended complaint was filed. January 05, 2023 - An investor in shares of BioLineRx Ltd. (NASDAQ: BLRX) filed a lawsuit in the U.S. District Court for the District of New Jersey yver alleged violations of Federal Securities Laws by BioLineRx Ltd. in connection with certain allegedly false and misleading statements made between February 23, 2021 and September 19, 2022....

You must register (for free) or login to view the entire case.